Subject |
Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. |
- Date of institutional investor conference:2022/12/28
- Time of institutional investor conference:15:00 (GMT+8)
- Location of institutional investor conference:Online Investor Conference
- Outline of institutional investor conference:Update the company's important new drug development progress and operating status.
Internet site:http://bit.ly/3Pb6SJh
- Any other matters that need to be specified:The presentation slides will be made publicly by being uploaded to Market Observation Post System according to the regulation.
|